Funding: Aberdeen Investments & Genomics Limited

Funding Provisional 86% confidence first seen

Type
Funding
Status
Provisional
First seen
2 November 2026, 10:51
Latest source
2 November 2026, 10:51
Sources
1
Aberdeen Investments CG Scottish Widows Growth LTAF Genomics Limited IP Group Scottish Widows Nyobolt Oxford Quantum Circuits Quantum Motion

The deal

Genomics Limited Undisclosed Other · announced 2 Nov 2026

Investors IP Group Scottish Widows Aberdeen Investments CG Scottish Widows Growth LTAF

Deal terms as reported in the coverage below.

Source coverage

Market development: Scottish Widows & Aberdeen Investments Tech.eu independent